Other common mutations in pancreatic carcinoma include mutation in p53, loss of expression of p16ink4a, and loss of the TGF beta signaling molecule SMAD4/dpc4 (deleted in pancreatic cancer 4) [1, 13–15]. Here, CDKN2A is linked to pancreatic neoplasm.